846 related articles for article (PubMed ID: 19494296)
21. Bcl10/Malt1 signaling is essential for TCR-induced NF-kappaB activation in thymocytes but dispensable for positive or negative selection.
Jost PJ; Weiss S; Ferch U; Gross O; Mak TW; Peschel C; Ruland J
J Immunol; 2007 Jan; 178(2):953-60. PubMed ID: 17202357
[TBL] [Abstract][Full Text] [Related]
22. Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.
Kingeter LM; Schaefer BC
J Immunol; 2008 Nov; 181(9):6244-54. PubMed ID: 18941215
[TBL] [Abstract][Full Text] [Related]
23. Differential requirement for Malt1 in T and B cell antigen receptor signaling.
Ruland J; Duncan GS; Wakeham A; Mak TW
Immunity; 2003 Nov; 19(5):749-58. PubMed ID: 14614861
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.
Ferch U; Kloo B; Gewies A; Pfänder V; Düwel M; Peschel C; Krappmann D; Ruland J
J Exp Med; 2009 Oct; 206(11):2313-20. PubMed ID: 19841089
[TBL] [Abstract][Full Text] [Related]
25. The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling.
Douanne T; Gavard J; Bidère N
J Cell Sci; 2016 May; 129(9):1775-80. PubMed ID: 27006117
[TBL] [Abstract][Full Text] [Related]
26. T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10.
Hamilton KS; Phong B; Corey C; Cheng J; Gorentla B; Zhong X; Shiva S; Kane LP
Sci Signal; 2014 Jun; 7(329):ra55. PubMed ID: 24917592
[TBL] [Abstract][Full Text] [Related]
27. Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis.
Wang X; Zhu L; Liao Z; Zhang F; Xu L; Xu Y; Chen S; Yang L; Zhou Y; Li Y
J Immunol Res; 2014; 2014():492872. PubMed ID: 24971370
[TBL] [Abstract][Full Text] [Related]
28. A20-mediated negative regulation of canonical NF-κB signaling pathway.
Pujari R; Hunte R; Khan WN; Shembade N
Immunol Res; 2013 Dec; 57(1-3):166-71. PubMed ID: 24242761
[TBL] [Abstract][Full Text] [Related]
29. The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation.
Palkowitsch L; Marienfeld U; Brunner C; Eitelhuber A; Krappmann D; Marienfeld RB
J Biol Chem; 2011 Mar; 286(9):7522-34. PubMed ID: 21199863
[TBL] [Abstract][Full Text] [Related]
30. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.
Tokunaga F; Nishimasu H; Ishitani R; Goto E; Noguchi T; Mio K; Kamei K; Ma A; Iwai K; Nureki O
EMBO J; 2012 Oct; 31(19):3856-70. PubMed ID: 23032187
[TBL] [Abstract][Full Text] [Related]
31. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
[TBL] [Abstract][Full Text] [Related]
32. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.
Zhou H; Wertz I; O'Rourke K; Ultsch M; Seshagiri S; Eby M; Xiao W; Dixit VM
Nature; 2004 Jan; 427(6970):167-71. PubMed ID: 14695475
[TBL] [Abstract][Full Text] [Related]
33. MALT1-ubiquitination triggers non-genomic NF-κB/IKK signaling upon platelet activation.
Karim ZA; Vemana HP; Khasawneh FT
PLoS One; 2015; 10(3):e0119363. PubMed ID: 25748427
[TBL] [Abstract][Full Text] [Related]
34. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
35. MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling.
Elton L; Carpentier I; Staal J; Driege Y; Haegman M; Beyaert R
FEBS J; 2016 Feb; 283(3):403-12. PubMed ID: 26573773
[TBL] [Abstract][Full Text] [Related]
36. Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation.
Bidère N; Snow AL; Sakai K; Zheng L; Lenardo MJ
Curr Biol; 2006 Aug; 16(16):1666-71. PubMed ID: 16920630
[TBL] [Abstract][Full Text] [Related]
37. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
Verstrepen L; Carpentier I; Verhelst K; Beyaert R
Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
[TBL] [Abstract][Full Text] [Related]
38. Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation.
Wegener E; Oeckinghaus A; Papadopoulou N; Lavitas L; Schmidt-Supprian M; Ferch U; Mak TW; Ruland J; Heissmeyer V; Krappmann D
Mol Cell; 2006 Jul; 23(1):13-23. PubMed ID: 16818229
[TBL] [Abstract][Full Text] [Related]
39. Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex.
Park Y; Jin HS; Liu YC
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9433-8. PubMed ID: 23690623
[TBL] [Abstract][Full Text] [Related]
40. A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-kappaB.
Stilo R; Varricchio E; Liguoro D; Leonardi A; Vito P
J Cell Sci; 2008 Apr; 121(Pt 8):1165-71. PubMed ID: 18349075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]